Clinical tools for evaluating congenital adrenal hyperplasia in resource-limited hospitals: a study at a tertiary hospital in Saudi Arabia

Key Points

• Growth velocity monitoring is crucial for assessing clinical control in children with congenital adrenal hyperplasia.
• Androstenedione testing provides important insights into hormonal levels in patients with 21-OHD.
• The findings suggest that simplified monitoring frameworks can be beneficial for resource-limited hospitals.
• Larger studies are needed to validate the effectiveness of these clinical tools in different hospital settings.